Loading
Total declarations
Companies
▲ Purchases (214 ops.)
▼ Sales (22 ops.)
Latest filing published 22 Sept 2020 for LeonaBio, Inc..
Filing timeline
BuySaleJoseph Edelman
First 200 filings with a declared amount
Insider track record
Disclosed buys
214
Disclosed sells
22
Signal history
No signal scores available.
Closed purchases
Market purchases
214
Positive at T+90
57%
Median T+90
+2.1%
Based on 173 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -91.8%Entry 680.00 · Close at T+365 56.00
- -91.6%Entry 670.00 · Close at T+365 56.00
- -92.0%Entry 678.00 · Close at T+365 54.00
- -97.8%Entry 722.00 · Close at T+365 16.00
- -97.9%Entry 750.00 · Close at T+365 16.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Joseph Edelman: trading record in brief
Joseph Edelman is a declared insider at 6 companies; the most frequent names are XTL Biopharmaceuticals Ltd, Penwest Pharmaceuticals Co and Optimer Pharmaceuticals Inc. The record holds 237 filings, for trades running from 4 January 2005 to 22 September 2020.
Market trades split into 214 purchases (€98.0M) and 22 sales (€15.2M). Netting one side against the other leaves €82.8M of net buying. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2020 alone, the filings show 1 purchase and no sales.
In size, the median ticket on the buying side is €86k. After 173 purchases with a full 90-day history, the hit rate stands at 57% and the median 90-day move at +2.1%. These figures describe past trades and do not predict future prices.
The newest entry dates from 22 September 2020: a transaction, in LeonaBio, Inc. The most recent open-market purchase was published on 22 September 2020, 2,223 days ago. The median gap between a trade and its publication by SEC (Form 4) is 5 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Joseph Edelman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations229 total
1,644,785 shares0Common StockSEC:0001209191-20-051540:0
1,058,824 shares@ US$17.00100.0% of flowCommon StockSEC:0001209191-20-051540:1
Canonical exit: 21 Dec 2020 (T+90)
24,681,360 shares@ US$0.1409Ordinary SharesSEC:0000909012-08-001242:0
2,696,450 shares@ US$0.1528Ordinary SharesSEC:0000909012-08-001242:1
9,600,000 shares@ US$0.1528Ordinary SharesSEC:0000909012-08-001242:2
29,740 shares@ US$0.159Ordinary SharesSEC:0000909012-08-001242:3
400,000 shares@ US$0.1614Ordinary SharesSEC:0000909012-08-001242:4
1,943,250 shares@ US$0.1409Ordinary SharesSEC:0000909012-08-001242:5
400,000 shares@ US$0.1528Ordinary SharesSEC:0000909012-08-001242:6
299,570 shares@ US$0.1528Ordinary SharesSEC:0000909012-08-001242:7
3,000 shares@ US$5.00Ordinary SharesSEC:0000909012-08-001089:0
Canonical exit: 22 Jan 2009 (T+90)
4,500 shares@ US$5.00Ordinary SharesSEC:0000909012-08-001034:0
Canonical exit: 28 Dec 2008 (T+90)
300 shares@ US$5.00Ordinary SharesSEC:0000909012-08-001034:1
Canonical exit: 13 Jan 2009 (T+90)
27,500 shares@ US$5.00Ordinary SharesSEC:0000909012-08-001033:0
Canonical exit: 21 Sept 2008 (T+90)
3,500 shares@ US$5.00Ordinary SharesSEC:0000909012-08-001033:1
Canonical exit: 18 Sept 2008 (T+90)
192,000 shares@ US$7.40Common StockSEC:0000909012-08-000807:0
8,000 shares@ US$7.40Common StockSEC:0000909012-08-000807:1
48,960 shares@ US$3.23Ordinary SharesSEC:0000909012-08-000731:0
Canonical exit: 8 Sept 2008 (T+90)
2,040 shares@ US$3.23Ordinary SharesSEC:0000909012-08-000731:1
Canonical exit: 8 Sept 2008 (T+90)
96,000 shares@ US$3.37Ordinarry SharesSEC:0000909012-08-000713:0
Canonical exit: 3 Sept 2008 (T+90)
192,000 shares@ US$3.15Ordinary SharesSEC:0000909012-08-000713:1
Canonical exit: 3 Sept 2008 (T+90)
96,000 shares@ US$3.43Ordinary SharesSEC:0000909012-08-000713:2
Canonical exit: 4 Sept 2008 (T+90)
32,260 shares@ US$3.36Ordinary SharesSEC:0000909012-08-000713:3
Canonical exit: 7 Sept 2008 (T+90)
4,000 shares@ US$3.37Ordinary SharesSEC:0000909012-08-000713:4
Canonical exit: 3 Sept 2008 (T+90)
8,000 shares@ US$3.15Ordinary SharesSEC:0000909012-08-000713:5
Canonical exit: 3 Sept 2008 (T+90)
25 of 229 declarations
